Blood Cancer Discovery provides a critical outlet for high-impact basic, translational, and clinical research on all disease subtypes of leukemia, lymphoma, myeloma, and associated diseases. Read More ...

With over 12 million registered donors, DKMS has succeeded in doing this more than 115,000 times to date by providing blood stem cell donations to those in need. This accomplishment has led to ...

In a separate experiment, they instructed the stem cells to form a beating, heart-like structure, complete with a central chamber and a network of blood vessels. “This type of synthetic ...

Shinya Yamanaka of Japan, who discovered that specialized cells could be reprogrammed back to immature stem cells ... that are targeted in the blood are known as peripheral blood mononuclear ...

Blood stem cell transplants have been central players in treating blood cancers for decades. These procedures can improve patients’ chances of survival and can even offer the opportunity for a ...

Methods: We characterized the soluble factors (SFs) released by activated human CAR-T and CAR-NK cells and assessed their role in BMC activation (BMCA). Results: We found that SFs from both activated, ...

Treatment typically involves powerful chemotherapy, bone marrow/stem cell transplant, targeted therapy (tyrosine kinase inhibitors), monoclonal antibodies, and immunotherapy—used alone or in ...

The HEALEY ALS platform trial, which is simultaneously testing multiple potential treatments for amyotrophic lateral sclerosis (ALS), is amending its master protocol to allow a longer follow-up time ...

While he’s waiting on a firm prognosis after his blood cancer doctor left practice, Stewart says the disease will eventually kill him. But there is still hope. On Dec. 11, Stewart wrote a post on ...